openPR Logo
Press release

Trevigen Announces the First Standardized Comet Assay Electrophoresis System

07-14-2008 10:32 PM CET | Health & Medicine

Press release from: Trevigen, Inc.

Trevigen Announces the First Standardized Comet Assay

The comet assay is the only direct method for the detection of DNA damage in cells. It is used in cancer research, in genotoxicity studies on environmental mutagens, and for screening compounds for cancer therapeutics. Based on single cell gel electrophoresis in a controlled pH environment, the assay allows the integrity of stained nuclear DNA to be examined and measured.

Until now, a lack of standardization in electrophoresis equipment, control cells, comet slides and comet reagents created inconsistencies in data generated run-to-run, user-to-user, and lab-to-lab.

Trevigen, with funding from Phase 1 and Phase II SBIR grants, has solved these problems and makes available a novel complete assay system which includes CometSlides™, reagents, control cells and an electrophoresis unit which retains test cells in a uniquely configured electrophoretic field permitting consistent DNA migration patterns, which are critical for standardization of the assay. Each lot of the CometAssay™ control cells, reagents and CometSlides™developed by Trevigen are tested and qualified for use in the CometAssay™ System.
In combination, the components of the system permit reproducibility and reduce variability between individual users and different laboratories.

The subject of a Trevigen patent application, Trevigen’s new CometAssay™ ES is expected to make a major contribution to the refinement and regulation of the comet assay for cancer drug screening and genotoxicity studies. This system is targeted for release in the 4th quarter 2008.

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior.

Related products from Trevigen include CometAssay™ reagent kits, a variety of slides for low to high throughput assay platforms, FLARE™ assay kits for confirming the specificity of action of DNA damaging reagents and kits for the assay of drugs that inhibit the activity of poly(ADP)ribose polymerase (PARP). Visit www.trevigen.com or contact us at 800-873-8443 or info@trevigen.com for more information.

Trevigen’s CometAssay™ ES overcomes variations by placing an acrylic overlay on top of an elevated slide tray to maintain optimal buffer height for DNA migration. A constant buffer temperature is maintained using an underlying water jacket to cool the ceramic slide platform and buffer chamber. Notice the outlet valves for the water jacket on the right side of image. Specially designed slide trays are provided to accommodate 2, 20 and 96 well slides and maintain proper slide orientation in an electrophoretic field uniquely configured for single cell gel electrophoresis.

Press Contact: Belinda De Leon
Trevigen, Inc.
8405 Helgerman Court
Gaitherburg, MD 20877
www.trevigen.com
info@trevigen.com
1.800.873.8443

Trevigen is a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. A logical extension of the focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation. Currently, the product portfolio contains over 500 products categorized into four processes – Apoptosis, DNA Damage and Repair, Angiogenesis, and Oxidative Stress.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trevigen Announces the First Standardized Comet Assay Electrophoresis System here

News-ID: 48468 • Views:

More Releases from Trevigen, Inc.

HT PARP in vivo Pharmacodynamic Assay II
02-01-2010 | Sports
Trevigen, Inc.
HT PARP in vivo Pharmacodynamic Assay II
Trevigen announces a validated assay, with higher sensitivity and pre-coated antibody plates to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening. Pharmacodynamic (PD) assays have recently been developed and employed early in the drug screening process to assess the ability of potential drug candidates to affect molecular targets. These assays have the advantages of performing molecular proof-of-concept investigations at an early stage such as
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen announces the release of seven new coated well assay kits for cell adhesion studies. A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Assay
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Ass …
Poly(ADP-ribose) polymerase, through ribosylation of nuclear proteins, converts DNA Damage into intracellular signals that actuate either DNA repair or cell death. The development of inhibitors to PARP is of ever increasing interest in the drug discovery community since they can be used as modulators of DNA repair mediated resistance to cytotoxic cancer therapeutics. Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these
Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to “3-D” Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play

All 5 Releases


More Releases for Trevigen

Cell Culture Protein Surface Coatings Market 2021 Strategic Assessments - Cornin …
The "Cell Culture Protein Surface Coatings" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Cell Culture Protein Surface Coatings Industry presents a market overview, product details, classification, and market concentration. The report also provides an in-depth survey of key players in the market which is based on various competitive intelligence parameters like
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen announces the release of seven new coated well assay kits for cell adhesion studies. A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Ass …
Poly(ADP-ribose) polymerase, through ribosylation of nuclear proteins, converts DNA Damage into intracellular signals that actuate either DNA repair or cell death. The development of inhibitors to PARP is of ever increasing interest in the drug discovery community since they can be used as modulators of DNA repair mediated resistance to cytotoxic cancer therapeutics. Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these
Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit
Many scientists are converting from growing cells in a traditional 2-D monolayer on plastic surfaces with tissue culture medium to “3-D” Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complexstructures rather than uniform monolayers. Further, 3-D Cultures are grown on extracellular matrix proteins such as basement membrane extract and laminin I, which are known
Trevigen Launches LDEV Free Basement Membrane Extract
Trevigen launches LDVE Free Basement Membrane Extract within its Cultrex® product line of Cell Differentiation and Angiogenesis products. Basement Membrane Extract (BME) can be used for promotion and maintenance of a differentiated phenotype in a variety of cell cultures including primary epithelial cells, endothelial cells, and smooth muscle cells. Trevigen’s LDVE Free designation means that in addition to standard sterility, endotoxin and MAP testing, the BME is tested by
Trevigen Launches Cultrex® 24 Well Cell Invasion Assay Kits
Trevigen's Cultrex® 24 Well Cell Invasion Assay kits quantify the degree to which invasive cells penetrate either basement membrane extract, collagen I, collagen IV, or laminin I, in vitro. The kit uses Calcein AM to assay invasive properties of cells in response to stimulators or inhibitors. Utilizing a simplified Boyden chamber design with individual 8 µm polyester membrane inserts, the 24 well format allows users to independently coat